FIELD: medicine; neurology.
SUBSTANCE: present group of inventions concerns treating migraine. That is ensured by administering an effective amount of a partial NMDAR receptor agonist, CLYX-13 or a pharmaceutically acceptable salt thereof.
EFFECT: it provides the possibility of treating various migraine conditions by suppressing spreading and increasing refractory period of spreading depression in cerebral tissues.
18 cl, 11 dwg, 3 ex, 1 tbl
